BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
-7.42%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$5.38B
AUM Growth
-$480M
(-8.2%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
1.9%
Top 10 Holdings %
Top 10 Hldgs %
41.73%
Holding
223
New
22
Increased
133
Reduced
36
Closed
13
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$21.9M |
| 2 |
Glaukos
GKOS
|
$18.4M |
| 3 |
Arvinas
ARVN
|
$17.4M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$14.4M |
| 5 |
Becton Dickinson
BDX
|
$12.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$75.9M |
| 2 |
Gilead Sciences
GILD
|
$32.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$22.3M |
| 4 |
Teladoc Health
TDOC
|
$20M |
| 5 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$15.8M |
Sector Composition
| 1 | Healthcare | 94.28% |
| 2 | Industrials | 0.53% |
| 3 | Technology | 0.51% |
| 4 | Financials | 0.07% |
| 5 | Consumer Discretionary | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Agilent Technologies
A
$36.4B
| $2.28M | 0.04% |
29,800
-20,982
| -41% | -$1.61M |
|
127
Bio-Rad Laboratories Class A
BIO
$7.83B
| $2.25M | 0.04% |
+6,750
| New | +$2.25M |
|
|
BNFT
128
DELISTED
Benefitfocus, Inc.
BNFT
| $2.15M | 0.04% |
90,463
+2,300
| +3% | +$54.8K |
|
|
CTLT
129
DELISTED
CATALENT, INC.
CTLT
| $1.79M | 0.03% |
37,500
| – | – |
|
|
MDCO
130
DELISTED
Medicines Co
MDCO
| $1.45M | 0.03% |
28,900
-14,600
| -34% | -$730K |
|
131
Pfizer
PFE
$140B
| $1.44M | 0.03% |
42,160
| – | – |
|
132
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$60.5M
| $1.39M | 0.03% |
2,750
-2,850
| -51% | -$1.44M |
|
133
Ascendis Pharma
ASND
$12B
| $1.31M | 0.02% |
13,600
-4,600
| -25% | -$443K |
|
134
Johnson & Johnson
JNJ
$431B
| $1.29M | 0.02% |
+10,000
| New | +$1.29M |
|
|
MRTX
135
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.24M | 0.02% |
15,900
-5,600
| -26% | -$436K |
|
136
uniQure
QURE
$973M
| $1.22M | 0.02% |
30,900
+3,300
| +12% | +$130K |
|
|
GWPH
137
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.2M | 0.02% |
10,453
-1,900
| -15% | -$218K |
|
138
Regenxbio
RGNX
$476M
| $1.2M | 0.02% |
33,700
+600
| +2% | +$21.4K |
|
|
PTLA
139
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.17M | 0.02% |
+43,700
| New | +$1.17M |
|
|
BPMC
140
DELISTED
Blueprint Medicines
BPMC
| $1.16M | 0.02% |
15,800
+300
| +2% | +$22K |
|
141
Charles River Laboratories
CRL
$7.99B
| $1.1M | 0.02% |
+8,300
| New | +$1.1M |
|
|
ARNA
142
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.08M | 0.02% |
23,517
-23,400
| -50% | -$1.07M |
|
143
Teva Pharmaceuticals
TEVA
$21.2B
| $1.03M | 0.02% |
+150,000
| New | +$1.03M |
|
|
XLRN
144
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.02M | 0.02% |
+25,800
| New | +$1.02M |
|
145
Zai Lab
ZLAB
$3.34B
| $971K | 0.02% |
30,000
-70,000
| -70% | -$2.27M |
|
146
Labcorp
LH
$22.9B
| $936K | 0.02% |
6,487
-244
| -4% | -$35.2K |
|
147
Fate Therapeutics
FATE
$112M
| $933K | 0.02% |
60,100
+1,100
| +2% | +$17.1K |
|
|
ZGNX
148
DELISTED
Zogenix, Inc.
ZGNX
| $921K | 0.02% |
+23,000
| New | +$921K |
|
149
McKesson
MCK
$86B
| $810K | 0.02% |
5,924
-225
| -4% | -$30.8K |
|
|
LVGO
150
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $754K | 0.01% |
+43,220
| New | +$754K |
|